Vigil Neuroscience Inc (VIGL)
3.52
-0.02
(-0.56%)
USD |
NASDAQ |
May 17, 16:00
3.52
0.00 (0.00%)
After-Hours: 20:00
Vigil Neuroscience Shareholders Equity (Quarterly): 103.78M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 103.78M |
| December 31, 2023 | 116.25M |
| September 30, 2023 | 135.84M |
| June 30, 2023 | 153.84M |
| March 31, 2023 | 171.34M |
| December 31, 2022 | 189.08M |
| Date | Value |
|---|---|
| September 30, 2022 | 205.91M |
| June 30, 2022 | 150.63M |
| March 31, 2022 | 166.18M |
| December 31, 2021 | -69.44M |
| September 30, 2021 | -57.26M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-69.44M
Minimum
Dec 2021
205.91M
Maximum
Sep 2022
115.10M
Average
150.63M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
| TG Therapeutics Inc | 160.11M |
| Terns Pharmaceuticals Inc | 236.72M |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | 1.579M |
| iBio Inc | 9.197M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 125.08M |
| Total Liabilities (Quarterly) | 21.30M |